VCNX
Closed
Vaccinex Inc
5.63
0.00 (0.00%)
Last Update: 06 Sep 2024 23:00:00
Yesterday: 5.63
Day's Range: 5.39 - 5.64
Send
sign up or login to leave a comment!
When Written:
0.4099
Vaccinex Inc. is a clinical-stage biotechnology company that focuses on the discovery and development of therapeutic antibodies for the treatment of cancer and neurodegenerative diseases. The company's proprietary platform technology, called ActivMAb, is designed to identify and develop high-affinity antibodies that target specific disease-causing proteins. Vaccinex's lead product candidate, VX15/2503, is a monoclonal antibody that targets the semaphorin 4D (SEMA4D) protein, which is involved in tumor growth and immune suppression. The company is also developing other product candidates for the treatment of Huntington's disease, Alzheimer's disease, and multiple sclerosis. Vaccinex was founded in 2001 and is headquartered in Rochester, New York.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!